| 发明名称 |
USE OF AN ANTAGONIST MOLECULE FOR PREPARING A MEDICAMENT FOR TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS |
| 摘要 |
The present invention relates to predicting therapeutic response of treating patients suffering from itching and puritis mediated by cutaneous lymphocyte antigen positive T cells in atopic dermatitis. The invention also includes methods of predicting a therapeutically responsive patient population. |
| 申请公布号 |
IL219145(D0) |
申请公布日期 |
2012.06.28 |
| 申请号 |
IL20120219145 |
申请日期 |
2012.04.15 |
| 申请人 |
ZYMOGENETICS INC.;NATIONAL JEWISH HEALTH |
发明人 |
|
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
